Calcium borogluconate is primarily used in veterinary medicine, especially in the treatment of hypocalcemia (low blood calcium levels) in animals such as dairy cattle, sheep, and goats. Its justification for use in supporting the muscular system stems from well-established scientific understanding of calcium's role in muscle physiology. Calcium ions are essential for muscle contraction; when calcium levels fall below normal, animals can develop muscle weakness, tremors, and, in severe cases, tetany (involuntary muscle contractions) or paresis (partial paralysis). Supplementation with calcium borogluconate quickly restores serum calcium levels, thereby alleviating these muscular symptoms.

Numerous veterinary studies and clinical guidelines support the use of calcium borogluconate for the rapid correction of hypocalcemia and associated muscle dysfunction. For example, in dairy cows with parturient paresis ("milk fever"), intravenous or subcutaneous administration of calcium borogluconate leads to a marked and rapid improvement in muscle strength and function. This has been documented in peer-reviewed literature and is a standard practice in veterinary medicine. While the direct use of calcium borogluconate for muscle support in humans is not common, the scientific rationale for its effectiveness in the muscular system is robust and rooted in fundamental physiology.

In summary, the use of calcium borogluconate to support the muscular system is scientifically validated in the context of treating hypocalcemic conditions that impair muscle function.